$ALT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Altimmune, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Altimmune, Inc.. Get notifications about new insider transactions in Altimmune, Inc. for free.

Page: < prev 1 2 3 4 5 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 15 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Buy	J	0.00	21,357	0	88,163	66.8 K to 88.2 K (+31.97 %)
Dec 15 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Buy	J	0.00	16,018	0	141,163	125.1 K to 141.2 K (+12.80 %)
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,415
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	65,718	0	2,357,975	2.3 M to 2.4 M (+2.87 %)
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	242,694	0	2,292,257	2 M to 2.3 M (+11.84 %)
Dec 08 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.74	7,639	13,308	344,913	337.3 K to 344.9 K (+2.26 %)
Dec 08 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.80	16,106	28,996	337,274	321.2 K to 337.3 K (+5.01 %)
Dec 05 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.78	13,495	23,987	321,168	307.7 K to 321.2 K (+4.39 %)
Dec 05 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.81	7,300	13,195	307,673	300.4 K to 307.7 K (+2.43 %)
Dec 05 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.80	5,215	9,405	300,373	295.2 K to 300.4 K (+1.77 %)
Nov 30 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.84	12,978	23,816	295,158	282.2 K to 295.2 K (+4.60 %)
Nov 30 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.94	7,942	15,377	282,180	274.2 K to 282.2 K (+2.90 %)
Nov 30 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	1.97	12,395	24,445	274,238	261.8 K to 274.2 K (+4.73 %)
Nov 27 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.00	10,042	20,060	261,843	251.8 K to 261.8 K (+3.99 %)
Nov 27 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.02	6,505	13,162	251,801	245.3 K to 251.8 K (+2.65 %)
Nov 27 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.10	5,261	11,061	245,296	240 K to 245.3 K (+2.19 %)
Nov 21 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.06	7,236	14,905	240,035	232.8 K to 240 K (+3.11 %)
Nov 21 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.07	4,800	9,958	232,799	228 K to 232.8 K (+2.11 %)
Nov 21 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.12	6,295	13,352	227,999	221.7 K to 228 K (+2.84 %)
Nov 16 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	J	2.67	23	61	182
Nov 16 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	J	2.67	30	80	243
Nov 16 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	J	2.67	23	61	182
Nov 16 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Buy	J	0.00	12,030	0	22,418	10.4 K to 22.4 K (+115.81 %)
Nov 16 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Buy	J	0.00	16,039	0	66,806	50.8 K to 66.8 K (+31.59 %)
Nov 16 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Buy	J	0.00	12,030	0	125,145	113.1 K to 125.1 K (+10.64 %)
Nov 16 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,760
Nov 16 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	182,262	0	2,049,563	1.9 M to 2 M (+9.76 %)
Oct 17 2017	PIP	Altimmune, Inc.	SAYARE MITCHEL	Director	Option Exercise	A	2.50	20,000	50,000	20,000
Oct 17 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Option Exercise	A	2.50	20,000	50,000	20,000
Oct 17 2017	PIP	Altimmune, Inc.	Schafer Klaus	Director	Option Exercise	A	2.50	20,000	50,000	20,000
Oct 17 2017	PIP	Altimmune, Inc.	GILL JOHN	Director	Option Exercise	A	2.50	20,000	50,000	20,000
Oct 17 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	2.50	20,000	50,000	20,000
Oct 17 2017	PIP	Altimmune, Inc.	Hodges Philip	Director	Option Exercise	A	2.50	20,000	50,000	20,000
Oct 17 2017	PIP	Altimmune, Inc.	Hodges Philip	Director	Sell	J	0.00	1,278,471	0	0	1.3 M to 0 (-100.00 %)
Sep 26 2017	PIP	Altimmune, Inc.	Tasker Sybil	Chief Medical Offic ...	Option Exercise	A	2.48	50,000	124,000	50,000
Sep 26 2017	PIP	Altimmune, Inc.	Roberts M Scot	Chief Scientific Of ...	Option Exercise	A	2.48	50,000	124,000	50,000
Sep 26 2017	PIP	Altimmune, Inc.	Enright William	President and CEO	Option Exercise	A	2.48	125,000	310,000	125,000
Sep 26 2017	PIP	Altimmune, Inc.	CZEREPAK ELIZABETH	CFO and EVP Corp. D ...	Option Exercise	A	2.48	62,500	155,000	62,500
Sep 26 2017	PIP	Altimmune, Inc.	CZEREPAK ELIZABETH	CFO and EVP Corp. D ...	Option Exercise	A	2.48	62,500	155,000	62,500
Aug 28 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.25	50,000	112,390	221,704	171.7 K to 221.7 K (+29.12 %)
Aug 28 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.24	17,326	38,892	171,704	154.4 K to 171.7 K (+11.22 %)
Aug 24 2017	PIP	Altimmune, Inc.	Drutz David	Director	Buy	P	2.27	5,000	11,340	30,777	25.8 K to 30.8 K (+19.40 %)
Aug 24 2017	PIP	Altimmune, Inc.	Drutz David	Director	Buy	P	2.15	5,000	10,758	25,777	20.8 K to 25.8 K (+24.07 %)
Aug 23 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.22	43,352	96,350	154,378	111 K to 154.4 K (+39.05 %)
Aug 23 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.10	5,958	12,519	111,026	105.1 K to 111 K (+5.67 %)
Aug 23 2017	PIP	Altimmune, Inc.	SCHAFFER DERACE L	Director	Buy	P	2.02	690	1,395	105,068	104.4 K to 105.1 K (+0.66 %)
Aug 23 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	P	2.67	30,696	81,958	30,696
Aug 23 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	P	2.67	40,927	109,275	40,927
Aug 23 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	P	2.67	30,696	81,958	30,696
Aug 23 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	P	2.67	205	547	205
Aug 23 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	P	2.67	273	729	273
Aug 23 2017	PIP	Altimmune, Inc.	Truffle Capital S.A.S.	10% Owner	Option Exercise	P	2.67	205	547	205
Aug 23 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	P	2.67	465,086	1,241,780	465,086
Aug 23 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	P	2.67	3,104	8,288	3,104
Aug 18 2017	PIP	Altimmune, Inc.	Enright William	President and CEO	Option Exercise	M	0.08	91,733	7,339	0
Aug 18 2017	PIP	Altimmune, Inc.	Enright William	President and CEO	Option Exercise	M	0.08	71,644	5,732	0
Aug 18 2017	PIP	Altimmune, Inc.	Enright William	President and CEO	Buy	M	0.08	91,733	7,339	181,164	89.4 K to 181.2 K (+102.57 %)
Aug 18 2017	PIP	Altimmune, Inc.	Enright William	President and CEO	Buy	M	0.08	71,644	5,732	89,431	17.8 K to 89.4 K (+402.79 %)
Jun 08 2017	PIP	Altimmune, Inc.	Tasker Sybil	Chief Medical Offic ...	Option Exercise	A	4.12	40,000	164,800	40,000
Jun 06 2017	PIP	Altimmune, Inc.	GILL JOHN	Director	Buy	P	4.34	1,000	4,344	83,224	82.2 K to 83.2 K (+1.22 %)
May 08 2017	PIP	Altimmune, Inc.	Schafer Klaus	Director	Option Exercise	A	0.59	1,791	1,057	1,791
May 08 2017	PIP	Altimmune, Inc.	Schafer Klaus	Director	Option Exercise	A	0.08	1,791	143	1,791
May 08 2017	PIP	Altimmune, Inc.	Schafer Klaus	Director	Option Exercise	A	0.08	1,791	143	1,791
May 08 2017	PIP	Altimmune, Inc.	Schafer Klaus	Director	Option Exercise	A	0.08	4,775	382	4,775
May 08 2017	PIP	Altimmune, Inc.	Schafer Klaus	Director	Grant	A	0.00	5,998	0	5,998	0 to 6 K
May 08 2017	PIP	Altimmune, Inc.	Hodges Philip	Director	Grant	A	0.00	4,455	0	4,455	0 to 4.5 K
May 08 2017	PIP	Altimmune, Inc.	Hodges Philip	Director	Grant	A	0.00	36,785	0	36,785	0 to 36.8 K
May 08 2017	PIP	Altimmune, Inc.	Hodges Philip	Director	Grant	A	0.00	1,278,471	0	1,278,471	0 to 1.3 M
May 08 2017	PIP	Altimmune, Inc.	Roberts M Scot	Chief Scientific Of ...	Option Exercise	A	13.38	11,235	150,324	11,235
May 08 2017	PIP	Altimmune, Inc.	Roberts M Scot	Chief Scientific Of ...	Option Exercise	A	2.59	8,956	23,196	8,956
May 08 2017	PIP	Altimmune, Inc.	Roberts M Scot	Chief Scientific Of ...	Option Exercise	A	0.59	8,956	5,284	8,956
May 08 2017	PIP	Altimmune, Inc.	Roberts M Scot	Chief Scientific Of ...	Option Exercise	A	0.08	55,120	4,410	55,120
May 08 2017	PIP	Altimmune, Inc.	Enright William	See Remarks	Option Exercise	A	6.50	99,927	649,526	99,927
May 08 2017	PIP	Altimmune, Inc.	Enright William	See Remarks	Option Exercise	A	0.08	183,347	14,668	183,347
May 08 2017	PIP	Altimmune, Inc.	Enright William	See Remarks	Option Exercise	A	0.08	91,733	7,339	91,733
May 08 2017	PIP	Altimmune, Inc.	Enright William	See Remarks	Option Exercise	A	0.08	71,644	5,732	71,644
May 08 2017	PIP	Altimmune, Inc.	Enright William	See Remarks	Option Exercise	A	2.59	125,887	326,047	125,887
May 08 2017	PIP	Altimmune, Inc.	Enright William	See Remarks	Grant	A	0.00	17,787	0	17,787	0 to 17.8 K
May 08 2017	PIP	Altimmune, Inc.	CZEREPAK ELIZABETH	See Remarks	Option Exercise	A	13.38	18,727	250,567	18,727
May 08 2017	PIP	Altimmune, Inc.	CZEREPAK ELIZABETH	See Remarks	Option Exercise	A	13.35	178,595	2,384,243	178,595
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	0.59	4,177	2,464	4,177
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	0.08	4,178	334	4,178
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	0.08	4,178	334	4,178
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	0.08	2,090	167	2,090
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	0.08	1,791	143	1,791
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	0.08	1,791	143	1,791
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Option Exercise	A	0.08	4,755	380	4,755
May 08 2017	PIP	Altimmune, Inc.	Drutz David	Director	Grant	A	0.00	20,777	0	20,777	0 to 20.8 K
May 08 2017	PIP	Altimmune, Inc.	Tasker Sybil	See Remarks	Option Exercise	A	13.38	48,691	651,486	48,691
Jan 24 2017	PIP	PHARMATHENE, INC	Runge Jeffrey W.	Director	Option Exercise	M	3.11	20,000	62,200	0
Jan 24 2017	PIP	PHARMATHENE, INC	Runge Jeffrey W.	Director	Buy	M	3.11	20,000	62,200	197,700	177.7 K to 197.7 K (+11.25 %)
Jan 17 2017	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Option Exercise	M	2.20	20,000	44,000	0
Jan 17 2017	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Buy	M	2.20	20,000	44,000	1,043,782	1 M to 1 M (+1.95 %)
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Option Exercise	M	2.20	20,000	44,000	0
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Option Exercise	M	3.11	20,000	62,200	0
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Option Exercise	M	2.47	20,000	49,400	0
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Option Exercise	M	2.59	10,000	25,900	0
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Buy	M	2.20	20,000	44,000	205,004	185 K to 205 K (+10.81 %)
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Buy	M	3.11	20,000	62,200	185,004	165 K to 185 K (+12.12 %)
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Buy	M	2.47	20,000	49,400	165,004	145 K to 165 K (+13.79 %)
Jan 05 2017	PIP	PHARMATHENE, INC	St Peter Steven	Director	Buy	M	2.59	10,000	25,900	145,004	135 K to 145 K (+7.41 %)
Dec 22 2016	PIP	PHARMATHENE, INC	MACNEILL PHILIP	VP, CFO, Treasurer, ...	Option Exercise	M	1.66	17,657	29,311	35,312
Dec 22 2016	PIP	PHARMATHENE, INC	MACNEILL PHILIP	VP, CFO, Treasurer, ...	Option Exercise	M	1.71	5,000	8,550	5,000
Dec 22 2016	PIP	PHARMATHENE, INC	MACNEILL PHILIP	VP, CFO, Treasurer, ...	Buy	M	1.66	17,657	29,311	126,346	108.7 K to 126.3 K (+16.25 %)
Dec 22 2016	PIP	PHARMATHENE, INC	MACNEILL PHILIP	VP, CFO, Treasurer, ...	Buy	M	1.71	5,000	8,550	108,689	103.7 K to 108.7 K (+4.82 %)
Dec 09 2016	PIP	PHARMATHENE, INC	PRESCOTT GROUP CAPITAL MANAGEM ...	10% Owner	Sell	S	3.26	436,324	1,422,416	6,626,403	7.1 M to 6.6 M (-6.18 %)
Dec 09 2016	PIP	PHARMATHENE, INC	PRESCOTT GROUP CAPITAL MANAGEM ...	10% Owner	Sell	S	3.25	440,479	1,431,557	7,062,727	7.5 M to 7.1 M (-5.87 %)
Dec 09 2016	PIP	PHARMATHENE, INC	PRESCOTT GROUP CAPITAL MANAGEM ...	10% Owner	Sell	S	3.26	477,829	1,557,723	7,503,206	8 M to 7.5 M (-5.99 %)
Nov 30 2016	PIP	PHARMATHENE, INC	Runge Jeffrey W.	Director	Option Exercise	M	2.20	20,000	44,000	0
Nov 30 2016	PIP	PHARMATHENE, INC	Runge Jeffrey W.	Director	Buy	M	2.20	20,000	44,000	177,700	157.7 K to 177.7 K (+12.68 %)
Nov 23 2016	PIP	PHARMATHENE, INC	GILL JOHN	President and CEO	Option Exercise	M	2.20	100,000	220,000	0
Nov 23 2016	PIP	PHARMATHENE, INC	GILL JOHN	President and CEO	Buy	M	2.20	100,000	220,000	822,244	722.2 K to 822.2 K (+13.85 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	2.20	20,000	44,000	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	1.69	20,000	33,800	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	1.81	18,361	33,233	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	1.51	20,000	30,200	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	1.64	20,000	32,800	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	1.45	20,000	29,000	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	2.67	52,139	139,211	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	2.67	60,000	160,200	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	1.60	20,000	32,000	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Option Exercise	M	1.52	20,000	30,400	0
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	2.20	20,000	44,000	275,500	255.5 K to 275.5 K (+7.83 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	1.69	20,000	33,800	255,500	235.5 K to 255.5 K (+8.49 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	1.81	18,361	33,233	235,500	217.1 K to 235.5 K (+8.46 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	1.51	20,000	30,200	217,139	197.1 K to 217.1 K (+10.15 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	1.64	20,000	32,800	197,139	177.1 K to 197.1 K (+11.29 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	1.45	20,000	29,000	177,139	157.1 K to 177.1 K (+12.73 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	2.67	52,139	139,211	157,139	105 K to 157.1 K (+49.66 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	2.67	60,000	160,200	105,000	45 K to 105 K (+133.33 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	1.60	20,000	32,000	45,000	25 K to 45 K (+80.00 %)
Nov 23 2016	PIP	PHARMATHENE, INC	SAYARE MITCHEL	Director	Buy	M	1.52	20,000	30,400	25,000	5 K to 25 K (+400.00 %)
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Option Exercise	M	2.20	20,000	44,000	0
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Option Exercise	M	1.69	20,000	33,800	0
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Option Exercise	M	1.71	135,660	231,979	0
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Option Exercise	M	1.94	240,000	465,600	0
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Option Exercise	M	1.19	37,500	44,625	0
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Option Exercise	M	2.46	30,573	75,210	0
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Buy	M	2.20	20,000	44,000	898,055	878.1 K to 898.1 K (+2.28 %)
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Buy	M	1.69	20,000	33,800	878,055	858.1 K to 878.1 K (+2.33 %)
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Buy	M	1.71	135,660	231,979	858,055	722.4 K to 858.1 K (+18.78 %)
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Buy	M	1.94	240,000	465,600	722,395	482.4 K to 722.4 K (+49.75 %)
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Buy	M	1.19	37,500	44,625	482,395	444.9 K to 482.4 K (+8.43 %)
Nov 23 2016	PIP	PHARMATHENE, INC	RICHMAN ERIC I	Director	Buy	M	2.46	30,573	75,210	444,895	414.3 K to 444.9 K (+7.38 %)
Oct 04 2016	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Option Exercise	M	1.69	20,000	33,800	0
Oct 04 2016	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Option Exercise	M	1.51	20,000	30,200	0
Oct 04 2016	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Option Exercise	M	1.64	20,000	32,800	0
Oct 04 2016	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Option Exercise	M	1.45	20,000	29,000	0
Oct 04 2016	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Option Exercise	M	1.60	20,000	32,000	0
Oct 04 2016	PIP	PHARMATHENE, INC	SCHAFFER DERACE L	Director	Option Exercise	M	2.47	20,000	49,400	0

Page: < prev 1 2 3 4 5 5 next >